SUBSCRIBE
SUBSCRIBE

Phase I

Boston Scientific Commits to 10 More Years in SoCal Space, Plans to Hire
Drug Development
Vaxart Challenges Takeda with Oral Norovirus Vaccine
August 8, 2016
 · 
3 min read
Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission
Drug Development
AstraZeneca PLC Kills Six Pipeline Programs
July 28, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
ZIOPHARM Abandons $50 Million Stock Offering After Clinical Trial Deaths
July 15, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Drug Development
With Little Fanfare, Biogen Sneaks Lupus Drug Into a Phase I Trial
July 14, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
3 Nauseating Clinical Trial Flops of 2016 So Far
July 11, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Scancell Delays Melanoma Trial 9 to 12 Months to Whip Up New Batch of Cancer Vaccine
July 7, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
This Year’s Top 10 Disappointing Clinical Trials—So Far!
July 5, 2016
 · 
3 min read
First-Ever CRISPR Trials Points To Looming Problems
Biotech Bay
First-Ever CRISPR Trial Points to Looming Problems
June 27, 2016
 · 
5 min read
Biotech Startups Flock to the Suburbs Over Rising Rent Prices
Drug Development
Kite Pharma and Juno’s R&D Strategy to Reshape Cancer Treatment
June 21, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Scancell Suspends Dosing in Melanoma Trial Due to Quality Issues
June 17, 2016
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments
May 11, 2023
 · 
9 min read
Drug Development
Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 11, 2023
 · 
13 min read
Drug Development
Praxis Precision Medicines Announces Positive Topline Results from PRAX-628 Phase 1 Study Enabling Best-in-Class Profile
May 11, 2023
 · 
5 min read
Drug Development
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
May 11, 2023
 · 
8 min read
Drug Development
Oncocross Completes Phase I Global Clinical Trial of OC514, Treatment for Sarcopenia
May 10, 2023
 · 
1 min read
Drug Development
Codagenix Initiates Dosing in Phase 1 Study of Intranasal, Live-Attenuated RSV Vaccine, CodaVax™- RSV, in a Pediatric Population
May 10, 2023
 · 
4 min read
Drug Development
FSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohort
May 10, 2023
 · 
7 min read
Drug Development
Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered Intravenously, in Non-Small Cell Lung Cancer
May 10, 2023
 · 
6 min read
Drug Development
GENFIT Presents Phase 1 Clinical Data Evaluating NTZ at Digestive Disease Week® as part of its ACLF Program
May 9, 2023
 · 
6 min read
Drug Development
Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases
May 9, 2023
 · 
3 min read
Drug Development
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-355 in Patients with Solid Tumors Harboring Oncogene Amplification
May 9, 2023
 · 
6 min read
Drug Development
Anokion Announces New Clinical Data from the Phase 1 ACeD Trial Supporting KAN-101 as a Potential Disease-modifying Treatment for Celiac Disease
May 9, 2023
 · 
3 min read
Drug Development
Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001
May 9, 2023
 · 
3 min read
Drug Development
FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ Phase 1/2 Clinical Trial with Seclidemstat in Patients with Ewing Sarcoma
May 9, 2023
 · 
10 min read
Drug Development
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E Trial
May 9, 2023
 · 
8 min read
Drug Development
Seres Therapeutics Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination in the Gastrointestinal Microbiome
May 9, 2023
 · 
11 min read
Drug Development
HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration with Gilead, for Treatment of Hepatitis B
May 9, 2023
 · 
5 min read
Drug Development
FibroGen Enters into Exclusive License for FOR46 with Fortis Therapeutics
May 8, 2023
 · 
5 min read
Drug Development
Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
May 8, 2023
 · 
4 min read
Drug Development
New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023
May 8, 2023
 · 
8 min read
Load More